Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-11-27
2007-11-27
Hartley, Michael G. (Department: 1618)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S186000, C514S387000
Reexamination Certificate
active
10669217
ABSTRACT:
Disclosed is a method for treating or preventing Alzheimer's disease by restricting the level of metabolizable carbohydrate in the diet and/or administering to the patient an effective amount of an agent which reduces serum insulin levels.
REFERENCES:
patent: 4287200 (1981-09-01), Kawamatsu et al.
patent: 4340605 (1982-07-01), Kawamatsu et al.
patent: 4376777 (1983-03-01), Kawamatsu et al.
patent: 4438141 (1984-03-01), Kawamatsu et al.
patent: 4444779 (1984-04-01), Kawamatsu et al.
patent: 4461902 (1984-07-01), Kawamatsu et al.
patent: 4540564 (1985-09-01), Bodor
patent: 4546095 (1985-10-01), Markov
patent: 4572912 (1986-02-01), Yoshioka et al.
patent: 4683195 (1987-07-01), Mullis et al.
patent: 4683202 (1987-07-01), Mullis
patent: 4687777 (1987-08-01), Meguro et al.
patent: 4703040 (1987-10-01), Markov
patent: 4703052 (1987-10-01), Eggler et al.
patent: 4725610 (1988-02-01), Meguro et al.
patent: 4757052 (1988-07-01), Markov
patent: 4775665 (1988-10-01), Wurtman
patent: 4855306 (1989-08-01), Markstein et al.
patent: 4873191 (1989-10-01), Wagner et al.
patent: 4873255 (1989-10-01), Yoshioka et al.
patent: 4897393 (1990-01-01), Iijima et al.
patent: 4897405 (1990-01-01), Alessi et al.
patent: 4918091 (1990-04-01), Cantello et al.
patent: 4948900 (1990-08-01), Iijima et al.
patent: 4965188 (1990-10-01), Mullis et al.
patent: 4980350 (1990-12-01), MacCoss
patent: 5002953 (1991-03-01), Hindley
patent: 5039665 (1991-08-01), Markov
patent: 5039794 (1991-08-01), Wier et al.
patent: 5061717 (1991-10-01), Clark et al.
patent: 5120754 (1992-06-01), Clark et al.
patent: 5132317 (1992-07-01), Cantello et al.
patent: 5143929 (1992-09-01), Belliotti et al.
patent: 5164384 (1992-11-01), Paul
patent: 5194443 (1993-03-01), Hindley
patent: 5208250 (1993-05-01), Cetenko et al.
patent: 5223522 (1993-06-01), Clark et al.
patent: 5232925 (1993-08-01), Hindley et al.
patent: 5260445 (1993-11-01), Hindley
patent: 5270319 (1993-12-01), Belliotti et al.
patent: 5283260 (1994-02-01), Miller
patent: 5326770 (1994-07-01), Wilkerson
patent: 5364769 (1994-11-01), Rosenthal
patent: 5395822 (1995-03-01), Izumi et al.
patent: 5457109 (1995-10-01), Antonucci et al.
patent: 5463070 (1995-10-01), Goldstein
patent: 5468755 (1995-11-01), Cincotta
patent: 5472980 (1995-12-01), Miller
patent: 5478852 (1995-12-01), Olefsky et al.
patent: 5494927 (1996-02-01), Cetenko et al.
patent: 5523314 (1996-06-01), Bue-Valleskey et al.
patent: 5534615 (1996-07-01), Baker et al.
patent: 5543297 (1996-08-01), Cromlish et al.
patent: 5545410 (1996-08-01), Fox et al.
patent: 5556843 (1996-09-01), Romeo et al.
patent: 5594015 (1997-01-01), Kurtz et al.
patent: 5597832 (1997-01-01), Michaelides et al.
patent: 5602120 (1997-02-01), Fu et al.
patent: 5602121 (1997-02-01), Fu
patent: 5607967 (1997-03-01), Friedman et al.
patent: 5612312 (1997-03-01), Moses et al.
patent: 5614541 (1997-03-01), Bäckström et al.
patent: 5618835 (1997-04-01), Wu et al.
patent: 5641796 (1997-06-01), Dominianni et al.
patent: 5646168 (1997-07-01), Goldstein
patent: 5668117 (1997-09-01), Shapiro
patent: 5700820 (1997-12-01), Vyas et al.
patent: 5707971 (1998-01-01), Fahy
patent: 5714470 (1998-02-01), Peet et al.
patent: 5716975 (1998-02-01), Bue-Valleskey
patent: 5783556 (1998-07-01), Clark et al.
patent: 5789401 (1998-08-01), McCarty
patent: 5814647 (1998-09-01), Urban et al.
patent: 5824692 (1998-10-01), Lippiello et al.
patent: 5925657 (1999-07-01), Seed et al.
patent: 5935927 (1999-08-01), Vitek et al.
patent: 6025157 (2000-02-01), Klein et al.
patent: 6028088 (2000-02-01), Pershadsingh et al.
patent: 6087384 (2000-07-01), Matsui et al.
patent: 6117911 (2000-09-01), Grainger et al.
patent: 6191154 (2001-02-01), Landreth et al.
patent: 6399639 (2002-06-01), Matsui et al.
patent: 6555565 (2003-04-01), Matsui et al.
patent: 6746678 (2004-06-01), Shapiro
patent: 0 587 377 (1994-03-01), None
patent: 0 587 377 (1994-03-01), None
patent: 0 677 517 (1995-10-01), None
patent: 07-238035 (1995-09-01), None
patent: WO89/08651 (1989-09-01), None
patent: WO90/08832 (1990-08-01), None
patent: WO91/07107 (1991-05-01), None
patent: WO92/02520 (1992-02-01), None
patent: WO93/24115 (1993-12-01), None
patent: WO94/04133 (1994-03-01), None
patent: WO94/23756 (1994-10-01), None
patent: WO95/13823 (1995-05-01), None
patent: WO96/03087 (1996-02-01), None
patent: WO96/15272 (1996-05-01), None
patent: WO96/33724 (1996-10-01), None
patent: WO97/31907 (1997-09-01), None
patent: WO98/29411 (1998-07-01), None
patent: WO98/29415 (1998-07-01), None
patent: WO98/39006 (1998-09-01), None
patent: WO98/40386 (1998-09-01), None
patent: WO98/41201 (1998-09-01), None
patent: WO99/16758 (1999-04-01), None
patent: WO99/20614 (1999-04-01), None
patent: WO99/38850 (1999-08-01), None
patent: WO99/46268 (1999-09-01), None
patent: WO 00/23407 (2000-04-01), None
patent: WO 00/23415 (2000-04-01), None
patent: WO 00/23416 (2000-04-01), None
patent: WO 00/23417 (2000-04-01), None
patent: WO 00/23445 (2000-04-01), None
patent: WO 00/23451 (2000-04-01), None
patent: WO 00/32190 (2000-06-01), None
patent: WO 00/35437 (2000-06-01), None
Antonucci et al., “Impaired Glucose Tolerance is Normalized by Treatment With the Thiazolidinedione Troglitazone,” Diabetes Care 20:188-193 (1997).
Atkins, Robert C. M.D. and Atkins, Veronica.,Dr. Atkins' Quick&Easy New Diet Cookbook, Fireside, New York, NY, © 1997.
Balentine, “Pathology of Experimental Spinal Cord Trauma I. The Necrotic Lesion as a Function of Vascular Injury,” Lab. Invest. 39:236-253 (1978).
Banati et al., “Cytotoxicity of Microglia,” Glia 7.111-118 (1993).
Basso et al., “Graded Histological and Locomotor Outcomes after Spinal Cord Contusion Using the NYU Weight-Drop Device versus Transection,” Exp. Neurol. 139:244-256 (1996).
Bauer et al., “Expression and Regulation of Cyclooxygenase-2 in Rat Microglia,” Eur. J. Biochem. 243:726-731 (1997).
Beaudet, “Bibliography of Cloned Human and Other Selected DNAs,” Am. J. Hum. Genet. 37:386-406 (1985).
Berge et al., “Pharmaceutical Salts,” J. Pharm. Sciences 66:1-19 (1977).
Bernstein, H.G. et al., “Insulin-degrading enzyme in the Alzheimer's disease brain: prominent localization in neurons and senile plaques,” Neurosci. Lett. 263:161-4 (1999).
Berton and Gordon, “Modulation of Macrophage Mannosyl-Specific Receptors by Cultivation on Immobilized Zymosan, Effects on Superoxide-Anion Release and Phagocytosis,” Immunology 49:705-715 (1983).
Blight, “Effects of Silica on the Outcome From Experimental Spinal Cord Injury: Implication of Macrophages in Secondary Tissue Damage,” Neuroscience 60:263-273 (1994).
Blum-Degan, D. et al. “Altered regulation of brain glucose metabolism as a cause of neurodegenerative disorders?,” J. Neural Transm. Suppl. 46:139-47 (1995).
Borchelt et al., “Accelerated Amyloid Deposition in the Brains of Transgenic Mice Coexpressing Mutant Presenilin 1 and Amyloid Precursor Proteins,” Neuron 19:939-945 (1997).
Boshart et al., “A Very Strong Enhancer is Located Upstream of an Immediate Early Gene of Human Cytomegalovirus,” Cell 41:521-530 (1985).
Bradford, “A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye Binding,” Anal. Biochem. 72:248-254 (1976).
Bradley et al., “Formation of Germ-Line Chimaeras From Embryo-Derived Teratocarcinoma Cell Lines,” Nature 309:255-258 (1984).
Brennan, M.B., “Bringing Back the Memories. Expanding understanding of Alzheimer's disease drives development of new drugs,” Chem. Eng. News, pp. 29-32 and 34-35 (Jan. 20, 1997).
Brinster et al., “Factors Affecting the Efficiency of Introducing Foreign DNA into Mice by Microinjecting Eggs,” Proc. Natl. Acad. Sci. USA 82:4438-4442 (1985).
Brown et al., “Role of Microglia and Host Prion Protein in Neurotoxicity of a Prion Protein Fragment,” Nature 380:345-347 (1996).
Burridge and Chrzanowska-Wodni
de la Monte Suzanne
Esmond Robert W.
Wands Jack R.
de la Monte Suzanne
Esmond Robert W.
Finnegan Henderson Farabow Garrett & Dunner LLP
Hartley Michael G.
Samala Jagadishwar
LandOfFree
Method for treating or preventing Alzheimer's disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating or preventing Alzheimer's disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating or preventing Alzheimer's disease will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3812701